← Eichor
Study identifier: NCT05678413 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Role of Paclitaxel in Stricture Urethra

Condition: Stricture Urethra  ·  Sponsor: Al-Azhar University

PhaseNA
Planned participants200
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Stricture urethra is a common disease and has various causing factors. The most common performed procedure is direct visual internal urethrotomy (DVIU), but unfortunately has a high recurrence rates. Multiple trial were performed to improve the outcomes of DVIU. Various intralesional injections were used. in this trial we will evaluate intralesional paclitaxel injection following DVIU.

This description comes directly from the study's public registry record.

Talk to the study team

Mohamed F Salman, MD  ·  +201111788996  ·  prof_mohamed_fawzy@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Mohamed Fawzy SalmanCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05678413